Spectroscopic interactions of non-insulin-dependent diabetes mellitus with levocetirizine.


Journal

Pakistan journal of pharmaceutical sciences
ISSN: 1011-601X
Titre abrégé: Pak J Pharm Sci
Pays: Pakistan
ID NLM: 9426356

Informations de publication

Date de publication:
Jul 2021
Historique:
entrez: 20 11 2021
pubmed: 21 11 2021
medline: 1 3 2022
Statut: ppublish

Résumé

Non insulin dependent diabetes mellitus (NIDDM) drugs such as glibenclamide and metformin is employed to heterogeneous disorder characterized by alteration in production of glucose due to impairment of both insulin secretion and insulin action. These patients might suffer with allergic rhinitis and in this case, there is a possibility to maintain patient on levocetirizine, an anti-allergic drug commonly used in rhinitis. The object of the present study is to detect possible interaction between glibenclamide or metformin with levocetirizine Current study was performed using UV spectroscopic technique sing simultaneous equation in pH simulated to gastric juice (pH 1), pH 4, pH 7.4 and in pH 9. All drugs followed Beer Lambert's Law. Results showed that glibenclamide and metformin can increase or decrease availability of levocetirizine and in the same way levocetirizine can alter availabilities of glibenclamide and metformin in different pH. Hence, drug interaction between glibenclamide or metformin with levocetirizne occurred. This may be due to his may be due to the charge transfer or binding capabilities of these drugs which resulted in significantly changed availability of NIDDIM as well as levocetirizine. Therefore, co-administration of these drugs should be avoided and furtherinvestigations at clinical and pre-clinical levels should be done.

Identifiants

pubmed: 34799342

Substances chimiques

Hypoglycemic Agents 0
Solutions 0
levocetirizine 6U5EA9RT2O
Metformin 9100L32L2N
Glyburide SX6K58TVWC
Cetirizine YO7261ME24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1639-1644

Auteurs

Shafaque Mehboob (S)

Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan.

Moona Mehboob (M)

Department of Pharmaceutical Chemistry, School of Pharmacy, Dow University of Health Science, Karachi, Pakistan.

- Mehjabeen (-)

Department of Pharmacology, Faculty of Pharmaceutical Sciences, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan.

S M Tariq Rafi (SM)

Department of ENT, Jinnah Sindh Medical University, Karachi, Pakistan.

Tariq Khan (T)

Department of Pharmacology, Faculty of Pharmaceutical Sciences, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan.

Humaira Anser (H)

Department of Pharmacology, Institute of Pharmaceutical sciences, Jinnah Sindh Medical University, Karachi, Pakistan.

Shaheen Perveen (S)

Department of Pharmaceutics, Institute of Pharmaceutical sciences, Jinnah Sindh Medical University, Karachi, Pakistan.

Noor Jahan (N)

Department of Pharmacology, School of Pharmacy, Dow University of Health Science, Karachi, Pakistan.

Asma Wazir (A)

Department of Pharmacognocy, Faculty of Pharmaceutical sciences, Jinnah University for Women, Karachi, Pakistan.

Farah Owais (F)

Department of Pharmacology, Faculty of Pharmaceutical Sciences, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan.

Articles similaires

Humans Diabetes Mellitus, Type 2 Female Male Registries
Humans Diabetes Mellitus Aging Flavanones Hypoglycemic Agents

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines
Humans Diabetes Mellitus, Type 1 Hypoglycemia Patient Education as Topic Randomized Controlled Trials as Topic

Classifications MeSH